This randomised double-blind placebo-controlled study, led by St Vincent's Hospital Sydney, aims to examine the safety and efficacy of lisdexamfetamine in the treatment of adults with severe methamphetamine (MA) dependence.
Project Collaborators External
- Associate Professor Nadine Ezard (lead investigator)St Vincents & Mater Health Sydney
- Associate Professor Nicholas LintzerisUniversity of Sydney
- Associate Professor Robert Ali The University of Adelaide
- Professor Jason White University of South Australia
- Associate Professor Rebecca McKetin Australian National University
- James Ward South Australian Health and Medical Research Institute in Adelaide
- Mark MontebelloSouth Eastern Sydney Local Health District Drug and Alcohol Service
Project Supporters
NHMRC Project Grant
Expected date of completion
-
Project Area
Other
Project Contact
Professor Kate Dolan
- Overview
- News
- Our team
- References
